Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

Bookmark and Share
Published: 1 May 2014
Views: 2713
Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA

Dr Garrett talks to ecancertv at the AACR conference about her work surrounding HER2-targeted therapies and the ways in which resistance to treatment might be overcome by paying particular attention to fibroblast growth factor receptors (FGFRs) in strategies against breast cancer.

Read the article for more.